527 related articles for article (PubMed ID: 18653698)
21. A TLR2 ligand suppresses allergic inflammatory reactions by acting directly on mast cells.
Kasakura K; Takahashi K; Aizawa T; Hosono A; Kaminogawa S
Int Arch Allergy Immunol; 2009; 150(4):359-69. PubMed ID: 19571568
[TBL] [Abstract][Full Text] [Related]
22. LAT and NTAL mediate immunoglobulin E-induced sustained extracellular signal-regulated kinase activation critical for mast cell survival.
Yamasaki S; Ishikawa E; Sakuma M; Kanagawa O; Cheng AM; Malissen B; Saito T
Mol Cell Biol; 2007 Jun; 27(12):4406-15. PubMed ID: 17420272
[TBL] [Abstract][Full Text] [Related]
23. The PH domain adaptor protein Bam32/DAPP1 functions in mast cells to restrain FcɛRI-induced calcium flux and granule release.
Hou S; Pauls SD; Liu P; Marshall AJ
Mol Immunol; 2010; 48(1-3):89-97. PubMed ID: 20956018
[TBL] [Abstract][Full Text] [Related]
24. Distinct effects on M2-type pyruvate kinase are involved in the dimethylsulfoxide-induced modulation of cellular proliferation and degranulation of mast cells.
Koo N; Kim KM
Arch Pharm Res; 2009 Nov; 32(11):1637-42. PubMed ID: 20091279
[TBL] [Abstract][Full Text] [Related]
25. The role of Src family kinases in mast cell effector function.
Furumoto Y; Gomez G; Gonzalez-Espinosa C; Kovarova M; Odom S; Ryan JJ; Rivera J
Novartis Found Symp; 2005; 271():39-47; discussion 47-53, 95-9. PubMed ID: 16605127
[TBL] [Abstract][Full Text] [Related]
26. An IgE-dependent secretory response of mast cells can be induced by a glycosphingolipid-specific monoclonal antibody.
Schwarz A; Jürgens L; Licht A; Schneider H; Futerman AH; Pecht I
Eur J Immunol; 2000 Jan; 30(1):217-26. PubMed ID: 10602044
[TBL] [Abstract][Full Text] [Related]
27. Impaired tyrosine phosphorylation and Ca2+ mobilization, but not degranulation, in lyn-deficient bone marrow-derived mast cells.
Nishizumi H; Yamamoto T
J Immunol; 1997 Mar; 158(5):2350-5. PubMed ID: 9036984
[TBL] [Abstract][Full Text] [Related]
28. Resveratrol Suppresses Cytokine Production Linked to FcεRI-MAPK Activation in IgE-Antigen Complex-Exposed Basophilic Mast Cells and Mice.
Han SY; Choi YJ; Kang MK; Park JH; Kang YH
Am J Chin Med; 2015; 43(8):1605-23. PubMed ID: 26621445
[TBL] [Abstract][Full Text] [Related]
29. Differential regulation of phospholipase Cgamma subtypes through FcepsilonRI, high affinity IgE receptor.
Yoon E; Beom S; Cheong H; Kim S; Oak M; Cho D; Kim KM
Biochem Biophys Res Commun; 2004 Dec; 325(1):117-23. PubMed ID: 15522209
[TBL] [Abstract][Full Text] [Related]
30. Protein tyrosine phosphatase epsilon is a negative regulator of FcepsilonRI-mediated mast cell responses.
Akimoto M; Mishra K; Lim KT; Tani N; Hisanaga SI; Katagiri T; Elson A; Mizuno K; Yakura H
Scand J Immunol; 2009 May; 69(5):401-11. PubMed ID: 19508371
[TBL] [Abstract][Full Text] [Related]
31. FcepsilonRI beta-chain ITAM amplifies PI3K-signaling to ensure synergistic degranulation response via FcepsilonRI and adenosine receptors.
Nunomura S; Gon Y; Yoshimaru T; Kashiwakura J; Kawakami T; Ra C
Eur J Immunol; 2010 Apr; 40(4):1205-17. PubMed ID: 20101614
[TBL] [Abstract][Full Text] [Related]
32. Role of CC chemokines and their receptors in multiple aspects of mast cell biology: comparative protein profiling of FcepsilonRI- and/or CCR1-engaged mast cells using protein chip technology.
Toda M; Nakamura T; Ohbayashi M; Ikeda Y; Dawson M; Richardson RM; Alban A; Leed B; Miyazaki D; Ono SJ
Novartis Found Symp; 2005; 271():131-40; discussion 140-51. PubMed ID: 16605132
[TBL] [Abstract][Full Text] [Related]
33. Requirement of the tyrosines at residues 258 and 270 of MAIR-I in inhibitory effect on degranulation from basophilic leukemia RBL-2H3.
Okoshi Y; Tahara-Hanaoka S; Nakahashi C; Honda S; Miyamoto A; Kojima H; Nagasawa T; Shibuya K; Shibuya A
Int Immunol; 2005 Jan; 17(1):65-72. PubMed ID: 15569773
[TBL] [Abstract][Full Text] [Related]
34. An essential role for RasGRP1 in mast cell function and IgE-mediated allergic response.
Liu Y; Zhu M; Nishida K; Hirano T; Zhang W
J Exp Med; 2007 Jan; 204(1):93-103. PubMed ID: 17190838
[TBL] [Abstract][Full Text] [Related]
35. Positive and negative regulation of mast cell activation by Lyn via the FcepsilonRI.
Xiao W; Nishimoto H; Hong H; Kitaura J; Nunomura S; Maeda-Yamamoto M; Kawakami Y; Lowell CA; Ra C; Kawakami T
J Immunol; 2005 Nov; 175(10):6885-92. PubMed ID: 16272347
[TBL] [Abstract][Full Text] [Related]
36. Hyaluronic acid targets CD44 and inhibits FcepsilonRI signaling involving PKCdelta, Rac1, ROS, and MAPK to exert anti-allergic effect.
Kim Y; Lee YS; Hahn JH; Choe J; Kwon HJ; Ro JY; Jeoung D
Mol Immunol; 2008 May; 45(9):2537-47. PubMed ID: 18289679
[TBL] [Abstract][Full Text] [Related]
37. Regulation of mast cell activation by complement-derived peptides.
Erdei A; Andrásfalvy M; Péterfy H; Tóth G; Pecht I
Immunol Lett; 2004 Mar; 92(1-2):39-42. PubMed ID: 15081525
[TBL] [Abstract][Full Text] [Related]
38. MAPK kinase 3 specifically regulates Fc epsilonRI-mediated IL-4 production by mast cells.
MacNeil AJ; Yang YJ; Lin TJ
J Immunol; 2011 Sep; 187(6):3374-82. PubMed ID: 21841136
[TBL] [Abstract][Full Text] [Related]
39. Positive and Negative Regulatory Roles of C-Terminal Src Kinase (CSK) in FcεRI-Mediated Mast Cell Activation, Independent of the Transmembrane Adaptor PAG/CSK-Binding Protein.
Potuckova L; Draberova L; Halova I; Paulenda T; Draber P
Front Immunol; 2018; 9():1771. PubMed ID: 30116247
[TBL] [Abstract][Full Text] [Related]
40. Point mutations of 3BP2 identified in human-inherited disease cherubism result in the loss of function.
Miah SM; Hatani T; Qu X; Yamamura H; Sada K
Genes Cells; 2004 Nov; 9(11):993-1004. PubMed ID: 15507112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
